UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

Journal of hepatology, 2016-09, Vol.65 (3), p.579-588

2016

Volltextzugriff (PDF)

Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease

PloS one, 2015-08, Vol.10 (8), p.e0136822-e0136822

2015

Volltextzugriff (PDF)

A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori

The American journal of gastroenterology, 2011-11, Vol.106 (11), p.1970-1975

2011

Volltextzugriff (PDF)

Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease

American journal of physiology: Gastrointestinal and liver physiology, 2015-05, Vol.308 (9), p.G794-G803

2015

Volltextzugriff (PDF)

Vitamin E and nonalcoholic fatty liver disease

Current opinion in clinical nutrition and metabolic care, 2012-11, Vol.15 (6), p.641-648

2012

Volltextzugriff (PDF)

The Cardiovascular Link to Nonalcoholic Fatty Liver Disease

Clinics in liver disease, 2012-08, Vol.16 (3), p.599-613

2012

Volltextzugriff (PDF)

Prevalence of restless legs syndrome in patients with irritable bowel syndrome

World journal of gastroenterology : WJG, 2011-10, Vol.17 (39), p.4404-4407

2011

Volltextzugriff (PDF)

Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial

Therapeutic advances in gastroenterology, 2010-07, Vol.3 (4), p.221-225

2010

Volltextzugriff (PDF)

Vitamin E and nonalcoholic fatty liver disease

Current opinion in clinical nutrition and metabolic care, 2012-11, Vol.15 (6), p.641

2012

Volltextzugriff (PDF)

The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis

Clinics in liver disease, 2012-08, Vol.16 (3), p.599-613

2012

Volltextzugriff (PDF)

A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease

Transactions of the American Clinical and Climatological Association, 2015, Vol.126, p.271-288

2015

Volltextzugriff (PDF)

Recent advances in understanding/management of non-alcoholic steatohepatitis

F1000 prime reports, 2015-03, Vol.7, p.28-28

2015

Volltextzugriff (PDF)

Mo1037 Dysregulated Methionine Metabolism and Hyperhomocysteinemia in Diet-Induced Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-1019-S-1019

2013

Volltextzugriff (PDF)

A preclinical mouse model of nonalcoholic steatohepatitis and hepatocellular cancer that mimics human disease

Journal of hepatology, 2016

2016

Volltextzugriff (PDF)

Prevalence of Restless Leg Syndrome in Patients With Functional Bowel Disease in the Community: 1301

The American journal of gastroenterology, 2009-10, Vol.104, p.S485

2009

Volltextzugriff (PDF)

A Randomized Open-Label Clinical Trial With Levofloxacin, Omeprazole, Alinia® (Nitazoxanide), and Doxycycline (LOAD) Versus Lansoprazole, Amoxicillin and Clarithromycin (LAC) in the Treatment Naive Helicobacter pylori Population: 2009 ACG Auxiliary Award

The American journal of gastroenterology, 2009-10, Vol.104, p.S404

2009

Volltextzugriff (PDF)

693 The gp130/STAT3 Axis Is Modulated by Lipotoxic Stress and Activated in Humans With Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-922-S-922

2014

Volltextzugriff (PDF)

131 A Randomized Open-Label Clinical Trial with Levofloxacin, Omeprazole, Alinia (Nitazoxanide), and Doxycycline (LOAD) Versus Lansoprazole, Amoxicillin and Clarithromycin (LAC) in the Treatment Naive Helicobacter pylori Population

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-24-A-24

2009

Volltextzugriff (PDF)

Sequential Use of Nitazoxanide (NTZ) as a Salvage Therapy in Patient with Recurrent Mild to Moderate Clostridium Difficile Infection (CDI): A Prospective, Open-label, Randomized Clinical Trial: 386

The American journal of gastroenterology, 2010-10, Vol.105, p.S142

2010

Volltextzugriff (PDF)

Effect of Melatonin in Functional Heart Burn-A Randomized Placebo-Controlled Clinical Trial: 1345

The American journal of gastroenterology, 2010-10, Vol.105, p.S497

2010

Volltextzugriff (PDF)

694 Palmitate Induced Suppression of Macrophage THP-1 (Cd68+) Production of IGFBP-3: A Novel Mechanism of Lipotoxicity in the Liver

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-921-S-921

2012

Volltextzugriff (PDF)

Effects of Orally Disintegrated Metoclopramide (ODM) in Optimizing Late Outpatient Endoscopy: A Randomized Double-Blind Placebo-Controlled Clinical Trial: 1438

The American journal of gastroenterology, 2010-10, Vol.105, p.S534-S535

2010

Volltextzugriff (PDF)

A New Four-day Regimen with Dexlansoprazole, Moxifloxacin, Amoxicillin, Nitazoxanide, and Doxycycline (DeMAND) in Helicobacter Pylori Therapy: An Open-label Randomized Clinical Trial: 216

The American journal of gastroenterology, 2010-10, Vol.105, p.S81

2010

Volltextzugriff (PDF)

Interferon Alfa Antibody (IFN alfa Ab) as a Useful Predictive Marker of Sustained Viral Response (SVR) for Therapy in Chronic Hepatitis C: 310

The American journal of gastroenterology, 2010-10, Vol.105, p.S115

2010

Volltextzugriff (PDF)

Retrospective Analysis of Pan Asian Outcome of Response to Therapy for Hepatitis C - A Multicenter Study (REPORT-C Study)-Interim Results: 339

The American journal of gastroenterology, 2009-10, Vol.104, p.S128

2009

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(38)
Buchkapitel
(1)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer

Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease

A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori

Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease

Vitamin E and nonalcoholic fatty liver disease

The Cardiovascular Link to Nonalcoholic Fatty Liver Disease

Prevalence of restless legs syndrome in patients with irritable bowel syndrome

Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial

Vitamin E and nonalcoholic fatty liver disease

The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis

A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease

Recent advances in understanding/management of non-alcoholic steatohepatitis

Mo1037 Dysregulated Methionine Metabolism and Hyperhomocysteinemia in Diet-Induced Nonalcoholic Fatty Liver Disease

A preclinical mouse model of nonalcoholic steatohepatitis and hepatocellular cancer that mimics human disease

Prevalence of Restless Leg Syndrome in Patients With Functional Bowel Disease in the Community: 1301

A Randomized Open-Label Clinical Trial With Levofloxacin, Omeprazole, Alinia® (Nitazoxanide), and Doxycycline (LOAD) Versus Lansoprazole, Amoxicillin and Clarithromycin (LAC) in the Treatment Naive Helicobacter pylori Population: 2009 ACG Auxiliary Award

693 The gp130/STAT3 Axis Is Modulated by Lipotoxic Stress and Activated in Humans With Nonalcoholic Fatty Liver Disease

131 A Randomized Open-Label Clinical Trial with Levofloxacin, Omeprazole, Alinia (Nitazoxanide), and Doxycycline (LOAD) Versus Lansoprazole, Amoxicillin and Clarithromycin (LAC) in the Treatment Naive Helicobacter pylori Population

Sequential Use of Nitazoxanide (NTZ) as a Salvage Therapy in Patient with Recurrent Mild to Moderate Clostridium Difficile Infection (CDI): A Prospective, Open-label, Randomized Clinical Trial: 386

Effect of Melatonin in Functional Heart Burn-A Randomized Placebo-Controlled Clinical Trial: 1345

694 Palmitate Induced Suppression of Macrophage THP-1 (Cd68+) Production of IGFBP-3: A Novel Mechanism of Lipotoxicity in the Liver

Effects of Orally Disintegrated Metoclopramide (ODM) in Optimizing Late Outpatient Endoscopy: A Randomized Double-Blind Placebo-Controlled Clinical Trial: 1438

A New Four-day Regimen with Dexlansoprazole, Moxifloxacin, Amoxicillin, Nitazoxanide, and Doxycycline (DeMAND) in Helicobacter Pylori Therapy: An Open-label Randomized Clinical Trial: 216

Interferon Alfa Antibody (IFN alfa Ab) as a Useful Predictive Marker of Sustained Viral Response (SVR) for Therapy in Chronic Hepatitis C: 310

Retrospective Analysis of Pan Asian Outcome of Response to Therapy for Hepatitis C - A Multicenter Study (REPORT-C Study)-Interim Results: 339

Suchergebnisse filtern